[ad_1]
Investing.com – Biondvax Pharma ADR reported on Wednesday first quarter that beat analysts’ forecasts and income that was inline with expectations.
Biondvax Pharma ADR introduced earnings per share of ₪-0.005 on income of ₪0.00. Analysts polled by Investing.com anticipated EPS of ₪-0.17 on income of ₪0.00.
Biondvax Pharma ADR shares are down 42.55% from the start of the 12 months and are buying and selling at ₪1.350 , down-from-52-week-high.They’re under-performing the which is down 22.46% 12 months thus far.
Biondvax Pharma ADR shares gained 0.75% in intra-day commerce the report.
Biondvax Pharma ADR follows different main Healthcare sector earnings this month
Biondvax Pharma ADR’s report follows an earnings beat by Pfizer on Tuesday, Could 3, 2022, who reported EPS of ₪1.62 on income of ₪25.66B, in comparison with forecasts EPS of ₪1.49 on income of ₪24.1B.
Medtronic had missed expectations on Thursday, Could 26, 2022 with fourth quarter EPS of ₪1.52 on income of ₪8.09B, in comparison with forecast for EPS of ₪1.56 on income of ₪8.43B.
Keep up-to-date on all the upcoming earnings experiences by visiting Investing.com’s earnings calendar
[ad_2]
Supply hyperlink